INDAPTUS THERAPEUTICS, INC.

Profile

Company Names

INDAPTUS THERAPEUTICS, INC.

Addresses

3 COLUMBUS CIRCLE, NEW YORK, NY 10019

3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY 10019

Phone Numbers

(646) 427-2727
347-480-9760

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$34,993,907.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2025-06-12 
$2,314,800.00 
$5,000,000.00 
$2,685,200.00 
 
4
2025-01-16 
$2,246,500.00 
$2,246,500.00 
$0.00 
Equity 
3
2024-11-22 
$227,127.00 
$227,127.00 
$0.00 
 
2
2024-08-07 
$205,480.00 
$205,480.00 
$0.00 
 
1
2021-07-23 
$30,000,000.00 
$30,000,000.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
J 
GILBERT 
DIRECTOR
INDAPTUS THERAPEUTICS, INC.
MARK 
J. 
GILBERT 
DIRECTOR
INDAPTUS THERAPEUTICS, INC.
WILLIAM 
B. 
HAYES 
DIRECTOR
INTEC PHARMA LTD.   |  INDAPTUS THERAPEUTICS, INC.
HILA 
 
KARAH 
DIRECTOR
LABSTYLE INNOVATIONS CORP.   |  DARIOHEALTH CORP.   |  CYREN LTD.   |  INDAPTUS THERAPEUTICS, INC.
HILA 
W. 
KARAH 
DIRECTOR
INTEC PHARMA LTD.   |  INDAPTUS THERAPEUTICS, INC.
HOONMO 
 
LEE 
DIRECTOR
DECOY BIOSYSTEMS, INC.   |  INDAPTUS THERAPEUTICS, INC.
WALT 
A 
LINSCOTT 
EXECUTIVE OFFICER
INTEC PHARMA LTD.   |  INDAPTUS THERAPEUTICS, INC.
WALT 
A. 
LINSCOTT 
EXECUTIVE OFFICER
INDAPTUS THERAPEUTICS, INC.
ANTHONY 
J. 
MADDALUNA 
DIRECTOR
INTEC PHARMA LTD.   |  INDAPTUS THERAPEUTICS, INC.
ROBERT 
E. 
MARTELL 
DIRECTOR
CURIS INC   |  INDAPTUS THERAPEUTICS, INC.
JEFFREY 
A. 
MECKLER 
EXECUTIVE OFFICER, DIRECTOR
INTEC PHARMA LTD.   |  INDAPTUS THERAPEUTICS, INC.
MICHAEL 
 
NEWMAN 
EXECUTIVE OFFICER, DIRECTOR
STKR.IT, INC.   |  QUINSAM CAPITAL CORP   |  GOLUB + CO SPONSOR FUND, LLC   |  MOONDOG VINEYARDS, LLC   |  INDAPTUS THERAPEUTICS, INC.   |  PENINSULA CAPITAL CORP.
MICHAEL 
J 
NEWMAN 
EXECUTIVE OFFICER, DIRECTOR
INDAPTUS THERAPEUTICS, INC.
MICHAEL 
J. 
NEWMAN 
EXECUTIVE OFFICER, DIRECTOR
DECOY BIOSYSTEMS, INC.   |  INDAPTUS THERAPEUTICS, INC.
BRIAN 
 
O-CALLAGHAN 
DIRECTOR
SANGART INC   |  PETRA PHARMA CORP   |  DECOY BIOSYSTEMS, INC.   |  INDAPTUS THERAPEUTICS, INC.   |  CPICS ICAT INVESTMENT LLC   |  CPICS TIRECO., LLC
ROGER 
J. 
POMERANTZ 
DIRECTOR
SERES HEALTH, INC.   |  X-VAX TECHNOLOGY, INC.   |  INTEC PHARMA LTD.   |  INDAPTUS THERAPEUTICS, INC.
NIR 
 
SASSI 
EXECUTIVE OFFICER
INTEC PHARMA LTD.   |  INDAPTUS THERAPEUTICS, INC.
ROGER 
 
WALTZMAN 
EXECUTIVE OFFICER
MOLECULAR TEMPLATES, INC.   |  INDAPTUS THERAPEUTICS, INC.
ROGER 
J. 
WALTZMAN 
EXECUTIVE OFFICER
MOLECULAR TEMPLATES, INC.   |  INDAPTUS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-06-20
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-06-12 
2025-01-22
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-01-16 
2024-12-06
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-11-22 
2024-10-04
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-08-07 
2024-08-22
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-08-07 
2021-08-05
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2021-07-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
PAULSON INVESTMENT COMPANY, LLC
000005670
NONE
NONE
PAULSON INVESTMENT COMPANY, LLC
5670
NONE
NONE
PAULSON INVESTMENT COMPANY, LLC
127831
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375